← Scoopfeeds — Intelligent news, curated.
Legend Biotech Corporation (LEGN) Price Target Raised to $49 on LB5006 Clinical Progress
business

Legend Biotech Corporation (LEGN) Price Target Raised to $49 on LB5006 Clinical Progress

Yahoo Finance · Jun 25, 2026, 12:40 PM · Also reported by 2 other sources

Legend Biotech Corporation (LEGN) Price Target Raised to $49 on LB5006 Clinical Progress

Read full story on Yahoo Finance → More top stories

Also covered by

MacRumors Apple Just Raised the Price of the MacBook Neo Investing.com Raspberry Pi stock surges after Jefferies raises price target

More in business

Investing.com
TSX trades higher as Micron earnings revive global technology sector
Investing.com
US Supreme Court strikes down Hawaii handgun limits
MarketWatch
Take a cue from the rich: Do a midyear financial check-in
Investing.com
Interlink Electronics added to Russell Microcap Index
Investing.com
Senior US diplomat says Taiwan arms sale does not hinge on China
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop